The science behind autologous fat grafting.
Elisa Bellini, Michele P Grieco, Edoardo Raposio
https://pubmed.ncbi.nlm.nih.gov/29188051/Actively Recruiting
Led by CERM INC. · Updated on 2025-05-31
40
Participants Needed
2
Research Sites
13 weeks
Total Duration
Researchers are evaluating Autologous Adipose Cell Therapy to improve skin rejuvenation and hair restoration. This therapy aims to overcome the limitations of traditional fat grafting and dermal fillers by isolating early-stage fat cells for better distribution and longer-lasting effects. The study focuses on assessing the safety, feasibility, and effectiveness of this therapy for conditions like wrinkles, fine lines, skin elasticity loss, pigmentation, hair thinning, and hair loss. Participants will receive the Autologous Adipose Cells therapy treatment, which involves processing fat cells from their own body to enhance skin and hair appearance. The therapy is monitored by the primary investigator for up to 25 weeks to evaluate outcomes. This study includes only one treatment group receiving this biological intervention. During the study, participants will undergo various assessments including imaging, satisfaction surveys, and evaluation reports from the first visit before treatment through the last follow-up visit between weeks 16 and 25. The plastic surgeon will monitor treatment effects and safety over a six-month period. The total involvement spans from initial treatment to multiple follow-ups to track skin and hair improvements and participant satisfaction.
CONDITIONS
Autologous Adipose Cells Therapy
A
Ankeet Dixit
W
Wing Nam Fung
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
CERM INC.
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Autologous Adipose Cells Therapy | Common Cosmetic Rejuvenation |
|---|---|---|
| What it is | A single‑arm investigational procedure using a person’s own fat cells to rejuvenate skin and hair | Available cosmetic treatments such as injectable fillers or neuromodulators used to improve volume, fine lines, and skin texture |
| Primary use | Rejuvenate aging‑affected skin and hair, including fine lines, volume loss, pigmentation, texture, and thinning | Restore facial volume, smooth wrinkles, and enhance skin appearance through injectables |
| Evidence status | Early‑phase investigation; safety and effectiveness are being evaluated in this trial | Widely used in clinical practice with substantial patient satisfaction, though long‑term retention varies |
| Important risks | Safety and risk profile are under study; not fully established | Risks include injection‑related bruising, swelling or rare complications depending on provider and product |
| Important limitations | Single‑group early‑phase design lacks a control arm for direct comparison | Results depend on technique, product choice and repeat sessions; outcomes may not last long |
| Patient impact | Not yet known; outcome measures include patient satisfaction and imaging assessments | Often leads to high satisfaction for volume restoration and wrinkle reduction |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Treatment duration not explicitly specified; safety and efficacy monitored up to 25 weeks after treatment.
Participants receive Autologous Adipose Cells therapy treatment.
Multiple visits for treatment and monitoring over up to 25 weeks
Duration - Up to 25 weeks after treatment
Participants are monitored and evaluated by the primary investigator for treatment outcomes including safety, efficacy, and participant satisfaction.
Regular follow-up visits from week 16 to week 25
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Elisa Bellini, Michele P Grieco, Edoardo Raposio
https://pubmed.ncbi.nlm.nih.gov/29188051/H Sutcliffe, P S Rawlinson, B Thakker...
https://pubmed.ncbi.nlm.nih.gov/3402073/Yang An, Guanhuier Wang, Xiao Li...
https://pubmed.ncbi.nlm.nih.gov/36042025/CERM INC.
Lead Sponsor